Farms.com Home   Ag Industry News

Farmers may benefit from Monsanto and Harvard research

Joint announcement made about protein science breakthrough

By Diego Flammini
Assistant Editor, North American Content
Farms.com

New research done by Monsanto and Harvard University may help farmers in the fight against insects and disease.

Using PACE (phage-assisted continuous evolution), researchers generated new insect control traits for crops and showed the ability to enhance proteins to deliver specific benefits to plants, or target plant pests.

The findings, published in Nature, show how protein science can be used in agriculture; Monsanto said farmers could benefit from the results.

Monsanto

“Farmers are continually challenged by effects of a changing climate, including increased insect pressure, disease and weed infestations,” Monsanto said in a release. “A broad-range of agriculture solutions are critical to help farmers address and manage these on-farm challenges in a sustainable way.”

Executives say the results can impact more than just the agriculture industry.

“Scientific breakthroughs like PACE technology are key to continue bringing solutions to farmers to help them get more out of every acre,” Tom Adams, VP of Biotechnology for Monsanto said in a press release.

Isaac T. Kohlberg, Harvard’s Senior Associate Provost and Chief Technology Development Officer said the PACE technology could “evolve tailor-made therapies for human disease.”

In its release, Monsanto said scientific breakthroughs will be critical to helping farmers find sustainable solutions and increase yields.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.